Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Fantastic news for our team who have been working on the INTERCOVID Study, which launched in April 2020. This week on 12th August 2022, the research findings cited in the New Yorker! This work was a combined effort from 43 institutions in 18 countries and involved more than two thousand pregnant women.

The main outcome of the study was the increased rate of preeclampsia and other conditions such as pre-term birth, severe infection, and ICU admission due to COVID-19. The data is significant as it shows us women with preeclampsia should be considered a particularly vulnerable group with regard to the risks posed by COVID-19.

Read the full New Yorker article here

Exciting times ahead as the second round of data collection started in February 2022 and is now close to publication, so keep an eye out for it!

Upcoming OxTalks

Our Research Groups